PAK4 is present in pathways for renal cell carcinoma, ErbB signaling (S6 Fig), focal adhesion, T-cell receptor signaling, and regulation of the actin cytoskeleton. This evidence concerns the gene EGFR and hereditary clear cell renal cell carcinoma.